Skip to content

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.

The Cancer Institute NSW Translational Cancer Research Capacity Building Grant aims to provide the NHMRC Advanced Health and Research Translation Centres with the funds to strengthen cancer research capacity in NSW and foster a collaborative culture of research to drive improvements in cancer care and outcomes for people living with cancer across the state.

Led by Professor Geoff Delaney, a Radiation Oncologist and Director of Cancer Services for South West Sydney Local Health District, the $7M program will  support the engine room of successful translational research by recruiting high calibre, talented early and middle career researchers (ECRs, MCRs) and PhD students across a broad range of scientific and professional backgrounds; collaborate with all translational research groups in NSW and build on the education, career development and networking that exists between them; and provide crucial administrative support to maintain the CAG’s collaborative research programmes, stimulate new ideas and co-ordinate recruitment, training and competitive funding opportunities.

Professor Delaney has over 30 years of clinical and research experience and over 20 years of leadership experience in complex, collaborative and strategic projects.

The funding will build upon the 'Big Ideas' initiative already established by the Cancer CAG and provide the areas of focus with dedicated support to further research translation and education. The Cancer CAG will build upon the strong foundations laid by the collaborations between the former Cancer Institute NSW Translational Cancer Research Centres (CONCERT and TCRN) and brings together over 1200 cancer professionals across the South East and South West of Sydney.  

Cancer Institute NSW announcment: https://www.cancer.nsw.gov.au/what-we-do/news/changing-the-face-of-liver-cancer-in-nsw

‘A World Turned Topsy Turvy’: Maridulu Budyari Gumal - SPHERE CCI&KT Platform Uses Art to Communicate COVID-19 Experiences

The 'Topsy Turvy' exhibition – created through a unique collaboration with SPHERE Council members and the SPHERE CCI&KT Strategic Platform –  uses art to document, share, and generate new insights into COVID-19 experiences.

Announcement of the Executive Director for Maridulu Budyari Gumal - SPHERE

I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE).  He commenced in the role on 1 July 2021.

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.